Article
Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.
Current cancer drug targets - 1 Jan 2016
Giordani Erika, Zoratto Federica, Strudel Martina, Papa Anselmo, Rossi Luigi, Minozzi Marina, Caruso Davide, Zaccarelli Eleonora, Verrico Monica, Tomao Silverio
Abstract excerpt
Gastrointestinal cancer treatment is based more on molecular biology that has provided increasing knowledge about cancer pathogenesis on which targeted therapy is being developed. Precisely, targeted therapy is defined as a "type of treatment that uses drugs, such as monoclonal antibodies or tyrosine kinase inhibitors, to identify and attack specific cancer cells". Nowadays, the United States Food and Drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
